Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cavagna

Showing results (511-520 of 527) with videos related to

Pageof 53
Sort By:
Nature Reviews. Rheumatology|January 7, 2021
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
The European Respiratory Journal|July 11, 2020
Methotrexate and rheumatoid arthritis associated interstitial lung diseasePierre-Antoine Juge, Joyce S Lee, Jessica Lau, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2024
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome ProjectSara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Clinical and Experimental Rheumatology|March 15, 2024
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobankAravinthan Loganathan, Giovanni Zanframundo, Akira Yoshida, et al.
Annals of the Rheumatic Diseases|March 19, 2025
The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS projectGiovanni Zanframundo, Eduardo Dourado, Iazsmin Bauer-Ventura, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Pageof 53

Showing results (511-520 of 527) with videos related to

Sort By:
Pageof 53
Nature Reviews. Rheumatology|January 7, 2021
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
The European Respiratory Journal|July 11, 2020
Methotrexate and rheumatoid arthritis associated interstitial lung diseasePierre-Antoine Juge, Joyce S Lee, Jessica Lau, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2024
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome ProjectSara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Clinical and Experimental Rheumatology|March 15, 2024
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobankAravinthan Loganathan, Giovanni Zanframundo, Akira Yoshida, et al.
Annals of the Rheumatic Diseases|March 19, 2025
The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS projectGiovanni Zanframundo, Eduardo Dourado, Iazsmin Bauer-Ventura, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Pageof 53